I would like to draw attention to the emerging challenges in treating dermatophytosis, particularly the increasing resistance posed by new fungal strains, such as Trichophyton indotineae. Dermatophytosis is the most common superficial fungal infection affecting the skin, hair, and nails. Although it is not considered life-threatening, its high prevalence and negative impact on patients' quality of life make it one of the most widespread infectious diseases in various populations...
Keshwania P, Kaur N, Chauhan J, Sharma G, Afzal O, Alfawaz Altamimi AS, et al. Superficial dermatophytosis across the world’s populations: potential benefits from nanocarrier-based therapies and rising challenges. ACS Omega. 2023;8(35):31575-99.doi:10.1021/acsomega.3c01988
Brito SC, Pinto MR, Alcântara LM, Reis NF, Durães TL, Bittar CT, et al. Spatio-temporal six-year retrospective study on dermatophytosis in Rio de Janeiro, Southeast Brazil: A tropical tourist locality tale. PLoS Negl Trop Dis. 2023;17(4):e0010865. doi:10.1371/journal.pntd.0010865
Nosratabadi M, Akhtari J, Jaafari MR, Yahyazadeh Z, Shokohi T, Haghani I, et al. In vitro activity of nanoliposomal amphotericin B against terbinafine-resistant Trichophyton indotineae Int Microbiol. 2024. doi:10.1007/s10123-024-00617-4
Liang G, Li X, Li R, Wen H, Gu J, Ran Y, et al. Chinese expert consensus on management of antifungalāresistant dermatophytoses (2024 edition). Mycoses. 2024;67(9):e13785. doi:10.1111/myc.13785
Mirhendi H, Aboutalebian S, Jahanshiri Z, Rouhi F, Shidfar MR, Chadeganipour AS, et al. Increasing and Alarming Prevalence of Trichophyton indotineae as the Primary Causal Agent of Skin Dermatophytosis in Iran. Mycoses. 2025;68(1):e70013.
Khanabadi,F. (2024). Therapeutic Challenges in Dermatophytosis: Resistance Expanding with New Strains. Hospital Practices and Research, 9(4), 542-543. doi: 10.30491/hpr.2025.509836.1482
MLA
Khanabadi,F. . "Therapeutic Challenges in Dermatophytosis: Resistance Expanding with New Strains", Hospital Practices and Research, 9, 4, 2024, 542-543. doi: 10.30491/hpr.2025.509836.1482
HARVARD
Khanabadi F. (2024). 'Therapeutic Challenges in Dermatophytosis: Resistance Expanding with New Strains', Hospital Practices and Research, 9(4), pp. 542-543. doi: 10.30491/hpr.2025.509836.1482
CHICAGO
F. Khanabadi, "Therapeutic Challenges in Dermatophytosis: Resistance Expanding with New Strains," Hospital Practices and Research, 9 4 (2024): 542-543, doi: 10.30491/hpr.2025.509836.1482
VANCOUVER
Khanabadi F. Therapeutic Challenges in Dermatophytosis: Resistance Expanding with New Strains. Hosp Pract Res, 2024; 9(4): 542-543. doi: 10.30491/hpr.2025.509836.1482